BIGFINITE
LIVE

Serial Number

87338248

Owner

Bigfinite Inc.

Attorney

LEIGH ANN LINDQUIST

First Use Date

Feb 17, 2014

Filing Date

Feb 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

BIGFINITE Trademark

Serial Number: 87338248 • Registration: 5467091

BIGFINITE is a trademark filed by Bigfinite Inc. on February 16, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Bigfinite Inc. (2 trademarks)

San Francisco, CA 94105

Entity Type: 03

Trademark Details

Filing Date

February 16, 2017

Registration Date

May 15, 2018

First Use Anywhere

February 17, 2014

First Use in Commerce

December 1, 2015

Published for Opposition

February 27, 2018

Goods & Services

Providing downloadable cloud based software for data management and processing in relation to the creation and production of pharmaceuticals in order to improve conformity with regulatory requirements and licensing procurement

Software as a service (SAAS) featuring software for use by others for data storage, analysis, process, control and management; Software as a service (SAAS) featuring software for use by others for the acquisition, record, visualization and knowledge generation of industrial processes data; Providing temporary use of Online non-downloadable software for the provision of data management, process, analysis and control via website; cloud computing services, namely cloud hosting provider services; Consulting services in the field of cloud computing; Computer programming services for commercial analysis and reporting; advanced analytic services related to computers in the nature of computer systems analysis; Big data related services, namely providing temporary use of online non-downloadable software for the management, storage, process, analysis and control of data; Advanced product research in the field of artificial intelligence; software development services featuring development of artificial intelligence; data analysis services for the identification of issues and inefficiencies within the pharmaceutical manufacturing processes; data analysis services for lowering manufacturing-quality issues in the field of biopharmaceuticals; analysis services of pharmaceutical manufacturing data and information provided by users through online software; consultancy relating to the pharmaceutical research; conducting of quality control evaluations and assessments of the deployed solutions, namely the implementation and customization of software applications, and the installed Internet of Things components developed by the company; Testing, authentication and quality control of the deployed solutions, namely the implementation and customization of software applications, and the installation of Internet of Things components services; Development of computer software for the compilation and analysis of data designed for use in the control of manufacturing processes; Design and development of computer software for the manufacturing industries; analysis and testing services of the installed Internet of Things components developed by the company and the big data projects performed through the cloud platform supplied by the company for the pharmaceutical and biotechnological industry to assure compliance with industry standards; Advisory services in the field of product development and quality improvement of pharmaceuticals provided through online software and software as a service; programming and development of computer software for data processing and analysis; software as a service provided on a cloud basis that allows users to provide information and data in the field of industrial processes through online website ensuring source traceability and changes-track control; providing temporary use of online-non-downloadable software for data management and processing in relation to the creation and production of pharmaceuticals in order to improve conformity with regulatory requirements and licensing procurement; Software as a service (SAAS) services featuring software for providing data analysis reports to users in the field of pharmaceutical and biotechnology; Software as a service (SAAS) services consisting of hosting of software programs to input manufacturing data by users and allow them to obtain analysis results identifying manufacturing inefficiencies; Software as a service (SAAS) featuring software for collecting, organizing, transmitting, receiving, sharing, analyzing and storing electronic data, text and graphics via communications networks; Software as a service (SAAS) featuring software for generating reports regarding to analysis of data, inefficiency issues, improvement possibilities and control of quality-issues; designing interactive computer software programs in the nature of productivity programs, database programs, reporting programs, graphics programs, analytical programs and global network programs for others; Software as a service (SAAS) platform featuring computer software for extracting manufacturing raw data information from the biopharmaceutical industry for use in the decision making process

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 28, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 28, 2025 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Aug 26, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Mar 17, 2025 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 4, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 30, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 15, 2023 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 1, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 1, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
May 15, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 27, 2018 NPUB
PUBLISHED FOR OPPOSITION
Feb 27, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 26, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 26, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 26, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 30, 2017 GNRN
NON-FINAL ACTION E-MAILED
May 30, 2017 GNRT
NON-FINAL ACTION WRITTEN
May 30, 2017 CNRT
ASSIGNED TO EXAMINER
May 11, 2017 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 13, 2017 AMPX
ASSIGNED TO LIE
Mar 10, 2017 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 23, 2017 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 23, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2017 NWOS
NEW APPLICATION ENTERED
Feb 20, 2017 NWAP